Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

207,361-207,420 of 319,975

filter-aware
29
The slide uses a table-like structure to compare four board members.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
30
The slide uses a structured table format to map committees to their specific oversight domains.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
31
Includes a specific quote from an ISS recommendation regarding majority voting standards.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
32
Uses a before-after framing to show how shareholder feedback led to specific governance improvements.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
33
Alkermes | Investor Presentation Deck | 56 slidesAlkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
34
The slide uses a two-column layout to contrast engagement with two different activist investors.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
35
This slide is part of a proxy contest defense, specifically attacking the credibility and suitability of the activist's nominees.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
36
The slide uses a two-column layout to contrast the 'Process' of board composition with the 'Decision Making' regarding specific nominees.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
37
The slide uses a red-themed table to highlight negative attributes of specific individuals.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
38
The slide uses a table-like structure to present a timeline of legal events and critical court commentary.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
39
The slide uses a checkmark matrix to demonstrate board competency across five key areas: Neuroscience, Financial/Transactional, Commercial, Medical/R&D, and Global Business.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
40
This is a proxy fight slide comparing incumbent board members against challenger nominees.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
41
The slide uses a sidebar callout to emphasize the Board's role in initiating the transformation.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
42
This is a defensive slide in a proxy contest context, contrasting board achievements with criticisms of activist nominees.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
43
Alkermes | Investor Presentation Deck | 56 slidesAlkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
44
Alkermes | Investor Presentation Deck | 56 slidesAlkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
45
Alkermes | Investor Presentation Deck | 56 slidesAlkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
46
Includes a diagram of brain pathways related to wakefulness and neurotransmitters.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
47
Includes a structural biology visualization of the Orexin 2 receptor.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
48
Alkermes | Investor Presentation Deck | 56 slidesAlkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
49
Includes a CEO quote and specific program metrics.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
50
The slide uses a list of governance attributes on the left and three donut charts on the right to illustrate compensation design.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
51
Alkermes | Investor Presentation Deck | 56 slidesAlkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
52
Values are in millions, unaudited.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
53
Financial disclosure table for Alkermes.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
54
Includes footnotes regarding weighted average shares and specific adjustments like share-based compensation, depreciation, and amortization.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
55
Includes a footnote regarding arbitration proceedings with Janssen Pharmaceutica N.V.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
56
Alkermes | Investor Presentation Deck | 56 slidesAlkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
01
Slide 1
Allego | Results Presentation Deck | 16 slidesAllego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Attention1 hit
02
Allego | Results Presentation Deck | 16 slidesAllego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Attention1 hit
03
Allego | Results Presentation Deck | 16 slidesAllego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a three-pillar structure to explain the business model: physical infrastructure (left), software platform (center), and service contracts (right).Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Interest1 hit
05
The slide uses a two-column layout to contrast financial performance with operational milestones.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Interest1 hit
06
The slide outlines a vertical integration strategy in energy procurement for EV charging infrastructure.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
07
The slide uses a three-part structure to detail the partnership scope, rollout status, and customer benefits.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
08
The slide uses a waterfall-style progression to show the growth of charging ports from existing to pipeline.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
09
Allego | Results Presentation Deck | 16 slidesAllego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
10
The slide uses a split layout with stacked bar charts on the left and numbered key takeaways on the right.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
11
The slide uses a split layout with charts on the left and key takeaways on the right.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
12
The slide uses a split layout with charts on the left and key takeaways on the right.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
13
Allego | Results Presentation Deck | 16 slidesAllego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
14
Allego | Results Presentation Deck | 16 slidesAllego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Action1 hit
15
The table provides a bridge between statutory loss and non-IFRS metrics like EBITDA and Free Cash Flow.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Action1 hit
16
Allego | Results Presentation Deck | 16 slidesAllego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
argenx SE | Investor Presentation Deck | 22 slidesargenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Setup1 hit
02
argenx SE | Investor Presentation Deck | 22 slidesargenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Setup1 hit
03
argenx SE | Investor Presentation Deck | 22 slidesargenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Setup1 hit
04
The slide uses a circular graphic element to emphasize the 'revolution' in autoimmunity.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Why1 hit
05
argenx SE | Investor Presentation Deck | 22 slidesargenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Why1 hit
06
The slide uses a hub-and-spoke style diagram to connect the central vision to four strategic pillars.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations 1 hit
07
The slide uses a central bar chart flanked by four strategic callout boxes.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
08
The slide uses a three-column layout for clinical data and a footer for publication logos.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
09
The slide uses a circular cluster diagram to represent four strategic pillars.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations 1 hit
10
The slide uses a hub-and-spoke style layout to organize strategic pillars.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a geographic split between US and Global markets to track approval timelines.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a hub-and-spoke visual metaphor to link the clinical class to the specific biological targets.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Roadmap1 hit
13
The slide uses a pyramid structure to represent market size, with smaller patient populations at the top and larger ones at the bottom.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Roadmap1 hit
14
The slide uses a visual representation of an antibody to explain its 'sweeping' mechanism.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Quick Win Big Bet1 hit
15
The slide combines immunofluorescence microscopy (left) with physiological data (right) to demonstrate the mechanism of action and therapeutic efficacy.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Quick Win Big Bet1 hit
16
Includes a biological mechanism diagram on the left and a clinical trial roadmap on the right.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Quick Win Big Bet1 hit